Eagle Strategies
IBB icon

Eagle Strategies’s iShares Biotechnology ETF IBB Stock Holding History

Eagle Strategies’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.66M Sell
22,132
-60
-0.3% -$12K 0.45% 52
2026
Q2 		$4.22M Buy
22,192
+1,055
+5% +$181K 0.42% 53
2026
Q1 		$3.57M Buy
21,137
+8,851
+72% +$1.51M 0.43% 58
2025
Q4 		$2.07M Sell
12,286
-43
-0.3% -$6.98K 0.26% 77
2025
Q3 		$1.78M Buy
12,329
+90
+0.7% +$12.3K 0.24% 90
2025
Q2 		$1.55M Sell
12,239
-561
-4% -$68.9K 0.24% 87
2025
Q1 		$1.64M Buy
12,800
+1,181
+10% +$160K 0.28% 71
2024
Q4 		$1.54M Buy
11,619
+354
+3% +$49.8K 0.27% 73
2024
Q3 		$1.64M Sell
11,265
-409
-4% -$59.2K 0.3% 70
2024
Q2 		$1.6M Buy
11,674
+9,883
+552% +$1.32M 0.31% 71
2024
Q1 		$246K Sell
1,791
-9,297
-84% -$1.27M 0.05% 236
2023
Q4 		$1.51M Sell
11,088
-75
-0.7% -$9.15K 0.32% 67
2023
Q3 		$1.37M Buy
11,163
+646
+6% +$82.2K 0.34% 66
2023
Q2 		$1.34M Buy
10,517
+143
+1% +$18.6K 0.32% 68
2023
Q1 		$1.34M Buy
10,374
+211
+2% +$27.6K 0.33% 62
2022
Q4 		$1.33M Buy
10,163
+515
+5% +$66.6K 0.4% 59
2022
Q3 		$1.13M Buy
9,648
+1,289
+15% +$160K 0.59% 41
2022
Q2 		$983K Buy
8,359
+4,101
+96% +$487K 0.36% 60
2022
Q1 		$555K Sell
4,258
-7,488
-64% -$975K 0.22% 79
2021
Q4 		$1.79M Buy
+11,746
New +$1.82M 0.7% 39

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
WestEnd Advisors
WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Eagle Strategies's IBB Position: Q3 2026 in Review

Eagle Strategies reduced its iShares Biotechnology ETF (IBB) stake by 0.27% in Q3 2026, selling an estimated $12K and leaving 22,132 shares worth $4.66M. The position accounts for 0.45% of the portfolio, ranked #52.

Eagle Strategies first reported a position in IBB in Q4 2021 and has held it in 20 quarters since. 700 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Eagle Strategies held 22,132 shares of iShares Biotechnology ETF worth $4.66M as of Q3 2026.
  • Eagle Strategies sold 60 iShares Biotechnology ETF shares in Q3 2026, an estimated $12K.
  • iShares Biotechnology ETF made up 0.45% of Eagle Strategies's portfolio in Q3 2026, its #52 holding.
  • Eagle Strategies first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 20 quarters since.
  • 700 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Eagle Strategies's 13F filing for Q3 2026, filed 16 Oct 2026.